.jpg)
The test analyzes tissue samples collected through biopsy or surgery to determine whether tumor cells are responsive to estrogen or progesterone. This information helps healthcare providers i
HrC-Screening, or Hormone Receptor Classification Screening, is a specialized diagnostic test designed to evaluate the presence of hormone receptors in cancerous tissues. This screening is especially important for cancers like breast and ovarian, where hormone receptor status directly influences treatment strategies and patient outcomes.
Cancers that are hormone-sensitive often progress silently, with symptoms appearing only in advanced stages. HrC-Screening allows for the identification of these cancers before they become symptomatic, enabling early medical attention and more effective treatment.
The screening process is vital for individuals with a family history of hormone-related cancers or those exposed to known risk factors. Regular screening helps monitor changes in hormone receptor status, guiding preventive measures and ongoing health management.
HrC-Screening supports informed decision-making by providing detailed insights into the biological characteristics of tumors. This information is crucial for tailoring treatment plans and avoiding unnecessary therapies, enhancing both patient outcomes and quality of life.
Early Detection: Identifies hormone receptor-positive cancers at an early stage, increasing the chances of successful treatment.
Personalized Treatment: Guides the selection of targeted hormonal therapies, improving treatment efficacy.
Accurate Results: Utilizes advanced laboratory techniques for precise detection of hormone receptors.
Minimally Invasive: Involves simple sample collection procedures, ensuring patient comfort and safety.
Cost-Effective: Prevents the need for more expensive late-stage treatments by enabling early intervention.
Expert Guidance: Results are interpreted by experienced professionals, providing clear recommendations for next steps.
Appointment Booking: Patients can schedule their HrC-Screeningtest at the diagnostic centre in Nashik. Staff provide guidance on the process and arrange sample collection at a convenient time.
Sample Collection: A small tissue biopsy or blood sample is collected under sterile conditions. The procedure is quick and minimally invasive, ensuring patient comfort.
Laboratory Analysis: The sample is analyzed using advanced techniques to detect estrogen and progesterone receptors. Results indicate the receptor status and the percentage of affected cells.
Report Delivery: After analysis, detailed reports are provided, including interpretations and recommendations for further action. Patients receive both digital and printed copies for easy reference.
Estrogen Receptor (ER) Status: Determines if tumor cells respond to estrogen, guiding hormone therapy choices.
Progesterone Receptor (PR) Status: Measures the presence of progesterone receptors, influencing treatment decisions.
Receptor Expression Percentage: Quantifies the proportion of cancer cells expressing hormone receptors, aiding in prognosis.
Molecular Biomarkers: Additional tests may be performed to assess genetic predispositions and molecular changes.
Advanced Technology: Equipped with state-of-the-art laboratory instruments for accurate and reliable results.
Experienced Professionals: Staffed by skilled pathologists and technicians who ensure precise analysis and interpretation.
Patient-Centric Care: Prioritizes patient comfort, confidentiality, and quick turnaround times for reports.
Affordable Services: Offers high-quality diagnostics at competitive prices, making preventive care accessible to all.
The HrC Screening Test is generally safe, with minimal risks. The primary risk is related to the blood draw, such as slight bruising or discomfort.
Specific preparation may be required, such as fasting or avoiding certain medications. Your healthcare provider will give you detailed instructions based on your individual situation.
This test plays a crucial role in early detection, which can lead to more effective treatment options. Early diagnosis often improves outcomes and survival rates for various health conditions.
The HrC Screening Test typically involves a blood draw or a tissue sample, depending on the specific biomarkers being evaluated. The sample is then analyzed in a laboratory.
